Advisory Alpha’s Zimmer Biomet ZBH Stock Holding History

Advisory Alpha’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-14	Closed	-$2K	–	676
2020 Q3	$2K	Buy	+14	New	+$1.83K	﹤0.01%	632
2020 Q2	–	Sell	-14	Closed	-$1.58K	–	643
2020 Q1	$1.58K	Hold	14	–	–	﹤0.01%	609
2019 Q4	$2.09K	Sell	14 -12	-46%	-$1.66K	﹤0.01%	658
2019 Q3	$3.34K	Buy	+26	New	+$3.36K	﹤0.01%	595
2019 Q2	–	Sell	-49	Closed	-$5.85K	–	671
2019 Q1	$5.85K	Buy	+49	New	+$5.57K	﹤0.01%	461

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Advisory Alpha's ZBH Position: Q4 2020 in Review

Advisory Alpha sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 14 shares — an estimated $2K sold.

Advisory Alpha first reported a position in ZBH in Q1 2019 and held it in 5 quarters. The position peaked at $5.85K in Q1 2019. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

Advisory Alpha reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
Advisory Alpha sold 14 Zimmer Biomet shares in Q4 2020, an estimated $2K.
Advisory Alpha first reported a position in Zimmer Biomet in Q1 2019 and held it in 5 quarters.
Advisory Alpha's Zimmer Biomet position peaked at $5.85K in Q1 2019.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on Advisory Alpha's 13F filing for Q4 2020, filed 16 Feb 2021.